2013 and Pharmaceutical Companies - Pharmacy Technician Pulse

Novo Nordisk industry membership reinstated

European Pharmaceutical Review

MARCH 18, 2025

Novo Nordisk has regained full membership with the Association of the British Pharmaceutical Industry (ABPI), following suspension in 2023. This action resulted after the pharmaceutical company made serious breaches of the ABPI Code of Practice in 2021.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies

STAT+: AI drug firm Recursion moves from survival to industry domination

STAT

AUGUST 19, 2024

SALT LAKE CITY — On paper, Recursion Pharmaceuticals shouldn’t have worked. The founders were a medical school dropout, an entrepreneur whose most recent success was with a custom sign-making e-commerce shop, and an exacting University of Utah scientist.

Medical Schools

Medical Schools Pharmaceutical Companies Pharmaceutical Companies

STAT+: Endo Health ordered to pay more than $1.5 billion in opioid criminal case

STAT

MAY 7, 2024

In the second-largest fine ever levied on a pharmaceutical company, Endo Health Solutions was ordered to pay nearly $1.1 billion in criminal penalties and another $450 million in criminal forfeiture for illegally marketing its Opana ER prescription opioid.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies

STAT+: Mid-year drug price hikes are back despite Inflation Reduction Act

STAT

AUGUST 24, 2023

At the start and halfway points of each year, many pharmaceutical companies raise drug prices to bolster revenue and reportedly fund new research. It’s almost a tradition. “It’s increasing prices on their existing portfolio. Continue to STAT+ to read the full story…

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies

Campaigners challenge NHS England’s latest plan to share patient data

pharmaphorum

MAY 26, 2021

The government’s last attempt to shake up patient data-sharing – 2013’s Care.data scheme – suffered from a number of false starts and was eventually shut down in 2016. People can opt out of the scheme by filling in a form and taking it to their GP before 23 June, but campaigners say this has not been communicated effectively.

Communication

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines

PDA revises report on glass container manufacturing

European Pharmaceutical Review

JULY 5, 2023

Having been originally published in 2007, then revised in 2013, this latest 2023 edition addresses evolving standards and container types. According the PDA, the standardised quality criteria in TR 43 are intended as a guidance overview for container manufacturers and for incoming container acceptance inspection at pharmaceutical companies.

Packaging

Packaging Documentation Pharmaceutical Companies Pharmaceutical Companies

Preventing fungal contamination in pharmaceuticals

European Pharmaceutical Review

MARCH 11, 2024

Employing MALDI-TOF MS for microbial identification in sterile drug manufacturing Fungal contamination in pharmaceutical cleaning facilities Case study examples Mould and yeast have been reported by several previous authors in numerous pharmaceutical cleanrooms , cold rooms, and controlled areas, according to the authors. Ahmed et al.

Sterile Compounds

Sterile Compounds Compounding Packaging Pharmaceutical Companies

Ensuring adequate sanitisation: disinfectant-resistant microbes in cleanrooms

European Pharmaceutical Review

JULY 12, 2022

More than 480 warning letters solely related to the failure to produce aseptic conditions because of deficient cleaning and disinfection systems for cleanrooms and their equipment, were issued by regulators between 2013 to 2018. Microbial resistance is one of the factors responsible for such failings.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies

NHS patient data upload delayed by two months, says UK

pharmaphorum

JUNE 8, 2021

The possibility of data being shared with third-parties including academic researchers and pharmaceutical companies – albeit pseudonymised – has raised concerns about whether the public is aware that they stand to lose control of private information on their physical, mental and sexual health.

Medical Records

Medical Records Pharmaceutical Companies Pharmaceutical Companies Communication

Using RWE in rare disease drug development: effective innovations with historical controls

European Pharmaceutical Review

SEPTEMBER 22, 2022

Dr Maier has over 25 years of experience in drug development and commercialisation at pharmaceutical companies in Europe, Canada, the United States and Asia. 2013 Oct; 48(10): 943–953. Published online 2013 Jul 2. Mayer-Hamblett N, Rosenfeld M, Treggiari MM et al. Pediatr Pulmonol. doi: 1002/ppul.22693. Thompson, LA.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies FDA Documentation

NHS data sharing scheme “on hold” as millions opt out

pharmaphorum

AUGUST 23, 2021

The possibility of data being shared with third-parties including academic researchers and pharmaceutical companies raised concerns about whether the public is aware that they stand to lose control of private information on their physical, mental and sexual health. Now that’s been set back indefinitely. survey conducted in July.

Medical Records

Medical Records Documentation Pharmaceutical Companies Pharmaceutical Companies

Taming cardiovascular risk: the promise of LDL cholesterol lowering therapeutics

European Pharmaceutical Review

FEBRUARY 1, 2024

In this Q&A, he explores the trends and challenges within the cardiovascular treatment space, as well as clinical development of the company’s lead candidate obicetrapib, a cholesterol ester transfer protein (CETP) inhibitor for lowering low-density lipoprotein-cholesterol (LDL-C) and ultimately reducing cardiovascular risk.

Documentation

Documentation Pharmaceutical Companies Pharmaceutical Companies

Patents: a necessary evil?

European Pharmaceutical Review

OCTOBER 19, 2022

Patents are often described as the ‘lifeblood’ of pharmaceutical companies. 1 However, patent protection for pharmaceutical products is an economic trade-off between providing monopoly rights that incentivise development of future products and permitting higher drug prices to recoup the investment. 23 April 2013.

FDA

FDA Dosage Pharmaceutical Companies Pharmaceutical Companies

Amarin Makes Moves towards Global Expansion of Vazkepa

Pharmaceutical Technology

SEPTEMBER 22, 2022

The pharmaceutical company is well on its way to achieving its goals with successful full reimbursements, already confirmed in the United Kingdom ( UK), and Sweden. GlobalData is the parent company of Pharmaceutical Technology. Following this, in 2019, the FDA approved Vazkepa for the reduction of cardiovascular risk.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies FDA Dosage

Why Are FDA Inspections So Ineffective and Disappointing?

The People's Pharmacy

MAY 8, 2023

Since the start of 2013, pharmaceutical companies based in the U.S. The Ranbaxy Debacle: Investigative reporter Katherine Eban described in detail a case of fraud at Ranbaxy Laboratories in India in her May 15, 2013, article in Fortune titled “ Dirty Medicine.” It’s on to the next news cycle and business as usual.

FDA

FDA Pharmaceutical Companies Pharmaceutical Companies Medical Schools

Fixed-dose combination: Considerations for design, formulation, manufacturing and analysis

Pharmaceutical Technology

OCTOBER 25, 2022

Pharmaceutical companies – and the FDA – are embracing FDCs. From 1990 through 2013, the FDA approved 131 FDC products, on average 5.7 The potential to extend the patent life and market exclusivity of a company’s APIs is a potent financial incentive. More FDC products flowing into pharma pipelines.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies Dosage Packaging

What can Rishi Sunak do for the UK’s pharma industry

Pharmaceutical Technology

NOVEMBER 4, 2022

The SME R&D tax credit scheme allows tax relief of up to 33% on qualifying R&D expenditure, which the former PM David Cameron’s cabinet introduced in April 2013. Furthermore, O’Meara says it would be important to standardize intellectual property (IP) policy to avoid confusion for researchers and companies. says O’Meara.

Documentation

Documentation Pharmaceutical Companies Pharmaceutical Companies

Pandemic Like Never Before – Continuous Manufacturing to the Rescue

Roots Analysis

MARCH 26, 2024

However, the road for transition from the conventional batch to continuous manufacturing requires a shift in variety of parameters and is still quite unclear to many of the pharmaceutical companies. The field has also witnessed various expansion initiatives undertaken by industry players during the period 2013-2020 (till January).

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies FDA

FOSTAIR inhaler – TOP questions & ANSWERS

Druggist

NOVEMBER 19, 2020

In this study treatment with Fostair (reliever & maintenance) was compared to treatment with Fostair (maintenance) and salbutamol inhaler as a reliever (NICE, 2013. GSK (a pharmaceutical company) ran an inhaler recycling scheme until September 2020. References: NICE (2013). How to use Fostair inhaler? NICE (2015).

Medical Records

Medical Records Pharmaceutical Companies Pharmaceutical Companies

Evaluating NMR relaxometry for antibody identification

European Pharmaceutical Review

SEPTEMBER 25, 2023

Gregory’s industrial career spans an employment history with several major pharmaceutical companies. 2013; 102(1): 52–61. He obtained his BS in Chemistry from St Xavier College, MS in Analytical Chemistry from Governors State University and a PhD in Analytical Chemistry from Northern Illinois University. 2007; 848(1): 79–87.

Compounding

Compounding Pharmaceutical Companies Pharmaceutical Companies FDA

Pharmaceutical microbiology: key developments 2022

European Pharmaceutical Review

JANUARY 16, 2023

” Tony Cundell: Contract manufacturing organisations (CROs), start-up companies, established pharmaceutical companies and regulatory agencies are having difficulty recruiting and retaining technically-trained personnel. Dr Tony Cundell has a PhD in Microbiology from the Lincoln University, New Zealand.

Vaccines

Vaccines FDA Research Laboratories Documentation

How will NICE fare in a post-Brexit world?

pharmaphorum

MAY 14, 2021

Practically though, there are risks of additional processes and requirements (and expense) for pharmaceutical companies. It is also possible that companies may prefer to enter the EU market through the EMA process and avoid additional processes involving the MHRA and NICE.

Documentation

Documentation Pharmaceutical Companies Pharmaceutical Companies

Biogen’s $900 million settlement signals scrutiny on speaker fees

Pharmaceutical Technology

OCTOBER 5, 2022

Ferry describes a popular solution among pharmaceutical companies. Some companies try to separate the clinical educational programs from their sales programs, and the speaker programs are run through the clinical education programs. BIIB107 is a monoclonal antibody that targets ?4

Documentation

Documentation Pharmaceutical Companies Pharmaceutical Companies FDA

Race to the finish: pharma edges closer to approval with RSV vaccines

Pharmaceutical Technology

FEBRUARY 1, 2023

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.

Vaccines

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA

US legislative update: takeaways for European pharma

European Pharmaceutical Review

NOVEMBER 8, 2022

European pharmaceutical companies targeting the US market should be aware of these pending bills and their potential impacts on market entry, intellectual property enforcement and payer access. 136 (2013), [link] opinions/12pdf/12-416_m5n0.pdf. 3) policing anticompetitive settlements between competing drug manufacturers.

FDA

FDA Pharmaceutical Companies Pharmaceutical Companies

Top 20 BioPharma Companies Based on 2022 Total Revenue

PharmaShots

APRIL 12, 2023

Total Revenue: $28.54B Founded Year: 1876 Total Employees: ~21,000 Headquarters: Indianapolis, United States Market Cap: $344.98B Stock Exchange: NYSE With an idea to produce quality products, Eli Lilly and Company is an American Pharmaceutical company focused on discovering, developing, manufacturing, and marketing these products.

Vaccines

Vaccines FDA Pharmaceutical Companies Pharmaceutical Companies

The Best Probiotics for Hashimoto’s

The Thyroid Pharmacist

OCTOBER 28, 2022

Allegedly, the inventor left the company, along with his proprietary recipe, and the product that the VSL #3 manufacturer has been making is different than the clinically tested product. Published 2013 Apr 18. doi:10.1155/2013/767482. ScientificWorldJournal. 2013;2013:767482. Rodrigues AC, Cara DC, Fretez SH, et al.

Health and Personal Care Stores

Health and Personal Care Stores Immunization Grocery Stores Compounding

CMC Requirements for New Drug Registration in Latin America

ISPE

MAY 9, 2023

In an era when the world is accelerating the development of drugs and targeted medicines using innovative technologies, pharmaceutical companies still face registration hurdles for well-characterized molecules because of redundant or additional local regulatory requirements. 2013/C 223/01. Published 8 February 2013.

Documentation

Documentation Packaging Pharmaceutical Companies Pharmaceutical Companies

Top 20 Drugs with US Patent Expiry in 2023 Based on Total Sales Value

PharmaShots

MARCH 29, 2023

Shots: Drug patent expiry is when a patent granted to a pharmaceutical company for a particular drug expires, allowing other companies to produce and sell generic versions Like every other utility patent, pharmaceuticals also get market exclusivity of 20 years. Currently, the drug is not accessible in generic form.

FDA

FDA Chemotherapy Immunization Dosage

Nine for 2021: Addressing the pandemic legacy

pharmaphorum

JANUARY 14, 2021

Not so China, and especially not so the lead five European countries – on average European pharmaceutical companies saw a loss of 30% of the interactive time they previously had with healthcare professionals in 2020. Up to November, the US and Japan actually saw increases in interactive time in 2020. Pharma pivots East.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies Labelling

Thyroid Antibodies Part 2: Mechanisms to Reduce Thyroid Antibodies

The Thyroid Pharmacist

JULY 7, 2023

I really wish that this supplement would come back, and it’s one of the drug entities I would like to create if I ever win the lottery and start my own pharmaceutical company. The Journal of Clinical Endocrinology and Metabolism 2013:0021-972X. [60] The Journal of Clinical Endocrinology and Metabolism 2013:0021-972X. [61]

Immunization

Immunization Dosage Compounding Pharmaceutical Companies

What to Keep in Your Integrative Medicine Cabinet

The Thyroid Pharmacist

OCTOBER 27, 2023

The truth is that most supplement companies do not undergo the same scrutiny and testing that pharmaceutical products do, because many of the tests which are required of pharmaceutical companies are voluntary for supplement companies. Published 2013 Dec 26. 2013-3950. [30] Adv Exp Med Biol.

Health and Personal Care Stores

Health and Personal Care Stores Immunization Compounding Packaging

High biologics demand spurs need for greater contract manufacturing

Pharmaceutical Technology

APRIL 24, 2023

The US accounts for almost half of all biotechnology patents filed worldwide from 1999 to 2013. As a result, some pharmaceutical companies are turning to third parties. According to a Brookings study, the US has always been a global leader in the sector. Moreover, skilled manpower is required to run these facilities.

Vaccines

Vaccines Compounding Pharmaceutical Companies Pharmaceutical Companies

Pharmacy Technician Pulse

Novo Nordisk industry membership reinstated

STAT+: AI drug firm Recursion moves from survival to industry domination

Trending Sources

STAT+: Endo Health ordered to pay more than $1.5 billion in opioid criminal case

STAT+: Mid-year drug price hikes are back despite Inflation Reduction Act

Campaigners challenge NHS England’s latest plan to share patient data

PDA revises report on glass container manufacturing

Preventing fungal contamination in pharmaceuticals

Ensuring adequate sanitisation: disinfectant-resistant microbes in cleanrooms

NHS patient data upload delayed by two months, says UK

Using RWE in rare disease drug development: effective innovations with historical controls

NHS data sharing scheme “on hold” as millions opt out

Taming cardiovascular risk: the promise of LDL cholesterol lowering therapeutics

Patents: a necessary evil?

Amarin Makes Moves towards Global Expansion of Vazkepa

Why Are FDA Inspections So Ineffective and Disappointing?

Fixed-dose combination: Considerations for design, formulation, manufacturing and analysis

What can Rishi Sunak do for the UK’s pharma industry

Pandemic Like Never Before – Continuous Manufacturing to the Rescue

FOSTAIR inhaler – TOP questions & ANSWERS

Evaluating NMR relaxometry for antibody identification

Pharmaceutical microbiology: key developments 2022

How will NICE fare in a post-Brexit world?

Biogen’s $900 million settlement signals scrutiny on speaker fees

Race to the finish: pharma edges closer to approval with RSV vaccines

US legislative update: takeaways for European pharma

Top 20 BioPharma Companies Based on 2022 Total Revenue

The Best Probiotics for Hashimoto’s

CMC Requirements for New Drug Registration in Latin America

Top 20 Drugs with US Patent Expiry in 2023 Based on Total Sales Value

Nine for 2021: Addressing the pandemic legacy

Thyroid Antibodies Part 2: Mechanisms to Reduce Thyroid Antibodies

What to Keep in Your Integrative Medicine Cabinet

High biologics demand spurs need for greater contract manufacturing

Stay Connected